Abstract:This study investigated the effects of estrogen on the bone regeneration potential of periodontal ligament stem cells (PDLSCs) derived from osteoporotic rats and seeded on a collagen-based composite scaffold [nano-hydroxyapatite/collagen/poly(L-lactide) (nHAC/PLA)]. For this purpose, 48 healthy 3-month-old Sprague-Dawley female rats were divided into 2 groups as follows: the bilaterally ovariectomized (OVX) rats and sham-operated rats. The PDLSCs were isolated at 3 months after surgery (by which time postmenopausal osteoporosis had developed). The effects of estrogen on the characteristics of these cells seeded in a culture plate and of the cells seeded on nHAC/PLA were then investigated. The PDLSC + nHAC/PLA constructs were implanted subcutaneously into the backs of severe combined immunodeficient (SCID) mice for 12 weeks in order to examine the role of estrogen in the bone formation ability of PDLSCs derived from osteoporotic rats. The results from methyl thiazolyl tetrazolium (MTT) assay revealed that the proliferation of the cells derived from the rats in the OVX group was significantly higher than that of the cells derived from the rats in the sham-operated group at the stage of logarithmic growth. The staining intensity of alkaline phosphatase (ALP) and the mineralization of the cells derived from the rats in the OVX group was significantly weaker than that of the cells from the rats in the sham-operated group. When the PDLSCs were seeded on nHAC/PLA, ALP activity, osteocalcin (OCN) secretion, mineral formation and the mRNA expression levels of ALP, OCN, estrogen receptor (ER) and ER in the cells derived from the rats in the OVX group were markedly decreased. Treatment with 17-estradiol (E2) significantly weakened the proliferative ability of the cells derived from the OVX group rats, and enhanced their osteogenic differentiation ability and the mRNA expression levels of ALP, OCN, ER and ER. When the constructs were implanted into the backs of SCID mice for 12 weeks, the results of histological analysis indicated that the constructs derived from the OVX group rats had a few newly formed bones and osteoids; however, a great number of newly formed bones and osteoids were present in the ones from the sham-operated group and the OVX + E2 group rats. Our findings further indicate that estrogen deficiency impairs the osteogenic differentiation potential of PDLSCs, and that ER plays an important role in the bone regeneration ability of PDLSCs. Estrogen enhances the bone regeneration potential of PDLSCs derived from osteoporotic rats and seeded on nHAC/PLA. This study may provide insight into the clinical management of periodontal bone tissue repair in postmenopausal women with the use of estrogen-mediated PDLSCs seeded on nHAC/PLA.

Estrogen regulates expression of osteoprotegerin and RANKL in human periodontal ligament cells through estrogen receptor beta.

Effect of estrogen receptor beta on the osteoblastic differentiation function of human periodontal ligament cells.

Effect of 17-β estradiol on the expression of receptor activator of nuclear factor κB ligand and osteoprotegerin of human periodontal ligament cells during their osteogenic differentiation

Estrogen deficiency leads to impaired osteogenic differentiation of periodontal ligament stem cells in rats.

Role of OPG/RANKL/RANK system during alveolar bone resorption and remodeling

Downregulation of Rankl and Rankl/Osteoprotegerin Ratio in Human Periodontal Ligament Cells During Their Osteogenic Differentiation

Estrogen regulates osteogenic differentiation of human periodontal ligament stem cells via Wnt/beta‐catenin signaling pathway

The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without 1α,25-dihydroxyvitamin D3

Up-regulation of Estrogen Receptor-Beta Expression During Osteogenic Differentiation of Human Periodontal Ligament Cells.

Oestrogen Receptors Are Involved in the Osteogenic Differentiation of Periodontal Ligament Stem Cells

Study on Estrogen Receptor Expression in Human Periodontal Ligament Stem Cells

Increased PELP1 Expression in Rat Periodontal Ligament Tissue in Response to Estrogens Treatment

Opposite Function of ERα and ERβ in Controlling 17Β-Estradiol-mediated Osteogenesis in Osteoblasts

Estrogen Enhances The Bone Regeneration Potential Of Periodontal Ligament Stem Cells Derived From Osteoporotic Rats And Seeded On Nano-Hydroxyapatite/Collagen/Poly(L-Lactide)

[Regulation of Receptor Activator of Nuclear Factor Kappab Ligand and Osteoprotegerin Expression by Prostaglandin E2 in Osteoblastic-Like Cells].

Effects of IL-1β on OPG and RANKL mRNA expression in human periodontal ligament fibroblasts

Effect of 17β-estradiol on the gene expression of estrogen receptors and estrogen related-receptor α in the periosteum-derived osteogenic cells

The Effect of Estrogen Deficiency on Receptor Activator of Nuclear Factor Kappa B Ligand and Osteoprotegerin Synthesis in Periapical Lesions Induced in Rats.

Effect of Raloxifene and Estrogen on IL-1β Expression in Periodontitis-Associated Alveolar Bone in Osteoporotic Rats

Osteogenic induction and 1,25-dihydroxyvitamin D3 oppositely regulate the proliferation and expression of RANKL and the vitamin D receptor of human periodontal ligament cells.

Estrogen-Related Receptor Alpha Is Involved In The Osteogenic Differentiation Of Mesenchymal Stem Cells Isolated From Human Periodontal Ligaments